Literature DB >> 14718412

Long-acting bronchodilators are the first-choice option for the treatment of stable COPD.

Mario Cazzola, Maria Gabriella Matera.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14718412     DOI： 10.1378/chest.125.1.9

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

Review 1.  Novel long-acting bronchodilators for COPD and asthma.

Authors:  M Cazzola; M G Matera
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

2.  Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.

Authors:  Walter Vincken; Joseph Aumann; Hungta Chen; Michelle Henley; Danny McBryan; Pankaj Goyal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-24

3.  Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.

Authors:  David Price; Daniel West; Guy Brusselle; Kevin Gruffydd-Jones; Rupert Jones; Marc Miravitlles; Andrea Rossi; Catherine Hutton; Valerie L Ashton; Rebecca Stewart; Katsiaryna Bichel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.